Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more
a developer of patient-specific expanded cellular therapies for use in the treatment of patients with diseases
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IYG | 94.00 | 0.38 | +0.41% |
| iShares US Financial Services ETF | |||
| CLOX | 25.55 | 0.02 | +0.06% |
| Eldridge AAA CLO ETF | |||
| HYSD | 20.10 | -0.02 | -0.12% |
| Columbia Short Duration High Yield ETF | |||
| UXJA | 38.10 | -0.33 | -0.87% |
| FT Vest U.S. Eq Uncppd Acceler ETF - Jan | |||
| EURL | 44.76 | -1.20 | -2.62% |
| Direxion Daily FTSE Europe Bull 3X ETF | |||
A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then VCYT could also see price increases.
| Ticker / NAME | Correlation To VCEL | 1D Price Change % | ||
|---|---|---|---|---|
| VCEL | 100% | +1.04% | ||
| VCYT - VCEL | 52% Loosely correlated | +0.90% | ||
| AXON - VCEL | 38% Loosely correlated | -3.32% | ||
| AMRN - VCEL | 36% Loosely correlated | -1.21% | ||
| CRSP - VCEL | 35% Loosely correlated | -5.10% | ||
| TECH - VCEL | 34% Loosely correlated | +0.08% | ||
More | ||||
The 50-day moving average for VCEL moved above the 200-day moving average on June 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Moving Average Convergence Divergence (MACD) for VCEL just turned positive on June 04, 2026. Looking at past instances where VCEL's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VCEL advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 208 cases where VCEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
VCEL broke above its upper Bollinger Band on June 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.807) is normal, around the industry mean (22.746). P/E Ratio (110.465) is within average values for comparable stocks, (37.261). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.488). VCEL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (8.518) is also within normal values, averaging (432.117).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.